Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/01/017318
CTRI/2019/01/017318
Not yet recruiting
Phase 3

Randomized double blind placebo controlled study of Outpatient misoprostol 50 µg oral versus 25 µg vaginal misoprostol for cervical priming to prevent induction of labour for post-dated pregnancy

Fluid Research Grant0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Fluid Research Grant
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Fluid Research Grant

Eligibility Criteria

Inclusion Criteria

  • •Singleton pregnancy between 39\-40 weeks
  • •Cephalic presentation with live fetus
  • •Bishop score \<6 at 39weeks
  • •Lack of current indication for Induction of labour
  • •Gestational Diabetes on Medical Nutrition Therapy

Exclusion Criteria

  • •Ruptured membranes
  • •Unexplained vaginal bleeding
  • •Prior uterine incision
  • •Gestational Hypertension
  • •Gestational Diabetes on Oral Hypoglycemic Agents \& Insulin
  • •Estimated fetal weight \>\= 4000gm
  • •Bad obstetric history
  • •Pregnancy by Assisted reproductive technology
  • •Malpresentations
  • •Multiple gestation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Assessment of efficacy of lithium in prevention of peripheral neuropathyChemotherapy induce peripheral neuropathy.
IRCT20160813029327N10Islamic Azad University44
Completed
Not Applicable
Randomized double-blind placebo-controlled study of the efficacy of food containing bovine lactoferrin for suppression of colorectal polypscolorectal polyps(adenomas)
JPRN-C000000182ational cancer center105
Active, not recruiting
Not Applicable
randomized double blind placebo controlled study on the efficacy of autologous autovaccine in house dust mite allergy - FIAVS
EUCTR2005-005534-12-DEThe Symbio Herborn Group GmbH24
Not yet recruiting
Phase 3
The Shepherd Foundation Study into Alzheimer's Disease
ACTRN12606000324516Melbourne Health60
Active, not recruiting
Phase 1
Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD – The ABACOPD StudyMedDRA version: 19.0 Level: LLT Classification code 10010953 Term: COPD exacerbation System Organ Class: 100000004855Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2012-003234-16-DEHannover Medical School represented by Hannover Clinical Trial Center GmbH980